A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus

NCT03339453 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoglycemia
Diabetes Mellitus, Type 1

Interventions

DRUG: Nasal Glucagon
DRUG: Intramuscular Glucagon

Sponsor

Eli Lilly and Company